单体核型急性髓细胞白血病的临床和实验室特征临床医学专业论文.docx

单体核型急性髓细胞白血病的临床和实验室特征临床医学专业论文.docx

  1. 1、本文档共43页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
单体核型急性髓细胞白血病的临床和实验室特征临床医学专业论文

PAGE PAGE IV 单体核型急性髓细胞白血病的临床和实验室特征 英文摘要 Clinical and laboratory characteristics of acute myelogenous leukemia patients with monosomal karyotype Abstract Objective: To investigate the clinical and genetic characteristics of the monomer karyotype acute myeloid leukemia (Monosomal karyotype acute myeloid leukemia, MK-AML) and MK prognosis Cases and methods: 1、We analyzed karyotype of 3743 cases of acute leukemia cases confirmed in Affiliated Hospital of Suzhou University from January 2007 to June 2012 and sorted out the 153 cases of ANLL monomer karyotype (MK-AML) cases, then analyzed their age, gender, FAB typing, peripheral blood, leukemia immunophenotyping, karyotype and further study of the clinical and genetic features of the MK-AML. 2、We selected the 27 MK-AML patients diagnosed in Affiliated Hospital of Suzhou University from January 2007 to October 2010 as the research object, we also selected and the 27 non-mononer karyotype AML patients as the control group. The analysis was performed in all cases by bone marrow cell morphology, cell immunophenotyping and karyotype analysis. The patients of MK-AML group and those of the control group all took induction therapy with IDA program (idarubicin the Star + cytarabine). Patients who achieved complete remission (CR) continued to take a variety of programs, including the program above and high-dose cytarabine、FA program (fludarabine, cytarabine) alternating consolidation and intensive treatment. Two MK-AML patients who achieved complete remission after induction therapy received allogeneic hematopoietic stem cell transplantation (Allogeneic hematopoietic stem cell transplantation, allo-HSCT). Comparatively analyze 27 MK-AML patients and 27 non-monomer karyotype AML patients of CR rate and overall survival (OS). Results: 1、There are 2056 abnormal karyotype patients of the 3743 diagnosed AML patients, of which the incidence of 153 MK-AML cases in 2056 cases diagnosed AML patients 英文摘要 单体核型急性髓细胞白血病的临床和实验室特征 accounted f

文档评论(0)

peili2018 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档